CliffBio
small molecule

ADVIL CONGESTION RELIEF

IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameADVIL CONGESTION RELIEF
Active ingredientIBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
Strength200MG;10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2010
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.